Betamethasone Sodium Phosphate And Betamethasone Acetate Injection, Suspension
Product Images NDC 0517-0799

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Betamethasone Sodium Phosphate And Betamethasone Acetate (NDC 0517-0799). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Regent, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Betamethasone Premier 1)

Structural Formula (Betamethasone Premier 1)
Chemical structure of Betamethasone Sodium Phosphate and Betamethasone Acetate, illustrating the steroid backbone with attached phosphate and acetate groups.*
FDA Label Image

Structural Formula (Betamethasone Premier 2)

Structural Formula (Betamethasone Premier 2)
Chemical structure diagram of betamethasone, representing the active ingredient in Betamethasone Sodium Phosphate and Betamethasone Acetate injection suspension.*
FDA Label Image

Premier Logo (Betamethasone Premier 3)

FDA Label Image

Container Label Premier (Betamethasone Premier 4)

Container Label Premier (Betamethasone Premier 4)
Label for Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP, 30 mg/5 mL (6 mg/mL) in a 5 mL multiple dose vial. The label indicates the product is sterile and Rx only, intended for intramuscular, intra-articular, intralesional, intrabursal, and intradermal use but not for intravenous use. Manufactured by American Regent, Inc.*
FDA Label Image

Carton Labeling Premier (Betamethasone Premier 5)

Carton Labeling Premier (Betamethasone Premier 5)
Packaging label for Betamethasone Sodium Phosphate and Betamethasone Acetate injectable suspension, USP 30 mg/5 mL (6 mg/mL), sterile. The label indicates it is for intramuscular, intra-articular, intralesional, intrabursal, and intradermal use. The product is a multiple-dose vial labeled Rx only, manufactured by American Regent, Inc. Storage and handling instructions are included, with a barcode and NDC 0517-0799-01.*
FDA Label Image

Beta Premier Serialization Label (Betamethasone Premier 6)

Beta Premier Serialization Label (Betamethasone Premier 6)
A label showing lot number 'TEST', expiration date '11 2020', GTIN 00305170799014, and serial number 0. The label includes a small 2D barcode. No brand or dosage information is visible on this label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.